Cosomil
Latest round
- Series A
Last raised
- Feb 2026
Total raised
- Undisclosed
Investors
- 5
About Cosomil
Based in Tokyo, Japan, and founded in 2022, Cosomil, Inc.a Cosomil operates as a biotechnology company that performs research and develops liquid biopsy technologies. The company was Co-founded by Kagamiyu (CEO), Sakamoto Shingo (CTO), Toru Komatsu, and Rikiya Watanabe. The company develops testing technology for medical treatments. It develops liquid biopsy technologies that can assist in the early detection of cancers and other illnesses. The firm develops healthcare solutions using fluorescent enzyme substrates and microdevices.
Who invested in Cosomil
5 investors across 1 round
See all investors in Cosomil
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 6, 2026
Amount
Undisclosed
Investors
Questions about Cosomil
Who invested in Cosomil?
Cosomil has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cosomil raised?
Cosomil has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cosomil last raise money?
Cosomil's most recent round on record is a Series A, in Feb 2026.
What does Cosomil do?
Based in Tokyo, Japan, and founded in 2022, Cosomil, Inc.
Where is Cosomil headquartered?
Cosomil is headquartered in Tokyo, Japan.
Which VCs invest in companies like Cosomil?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Cosomil's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Cosomil? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.